Perbedaan Organon Pharma Indonesia Tbk. dan King Tire Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan King Tire Indonesia Tbk. diperdagangkan di Rp110 (kapitalisasi pasar 396,79 M, volume 24 jam 13,12 jt). Perbedaan utamanya: King Tire Indonesia Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TYRE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 396,79 M |
Volume | — | 13,12 jt |
Lot | — | 131,16 rb |
Perputaran | — | 1,6 M |
Harga Rata-rata | — | 122,35 |
Nilai Transaksi | — | 1,6 M |
Harga Ekuilibrium Indikatif | — | 110 |
Volume Ekuilibrium Indikatif | — | 1,51 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT King Tire Indonesia Tbk (the Company) was established on August 2, 2010 based on Notarial Deed No. 01 of Humberg Lie, S.H., S.E., M.Kn., notary in Jakarta. The Company started its commercial operations in 2011. The Companys immediate parent entity is PT Kingland Investindo Nusantara. The controlling interest of the Company is owned by an individual namely Harris Muliawan.
Selengkapnya di halaman TYRE →